CD14(dim)/CD16(bright) monocytes in hemophagocytic lymphohistiocytosis

Eur J Immunol. 2001 Jun;31(6):1716-9. doi: 10.1002/1521-4141(200106)31:6<1716::aid-immu1716>3.0.co;2-x.

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is an extremely rare and highly lethal chronic inflammatory disease, which is mediated by proinflammatory cytokines. In the peripheral blood of a boy suffering from HLH, a chronic expansion of CD14(dim)/CD16(bright) inflammatory monocytes was detected. Compared with CD14(bright) monocytes, their immunophenotype correlated with more mature monocytic cells differentiating to macrophages: they showed lower expression of CD11b, CD64 and CD35. Such CD14(dim)/CD16(bright) monocytes produce the inflammatory cytokines IL-1beta, IL-6 and TNF-alpha. They fit in well with the pathophysiological concept of HLH as an inflammatory state of lymphocytes and of the monocyte/macrophage system. In the presented patient the percentage of these circulating inflammatory monocytes decreased over time during clinical response to immunosuppressive therapy. This finding may indicate that CD14(dim)/CD16(bright) monocytes represented the degree of inflammation in this extremely rare and highly lethal disease.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Cell Count
  • Cyclosporine / therapeutic use
  • Dexamethasone / therapeutic use
  • Etoposide / therapeutic use
  • HLA-DR Antigens / biosynthesis
  • Histiocytosis, Non-Langerhans-Cell / drug therapy
  • Histiocytosis, Non-Langerhans-Cell / immunology*
  • Histiocytosis, Non-Langerhans-Cell / physiopathology
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lipopolysaccharide Receptors / immunology*
  • Macrophage-1 Antigen / biosynthesis
  • Male
  • Monocytes / cytology
  • Monocytes / immunology*
  • Receptors, Complement 3b / biosynthesis
  • Receptors, IgG / biosynthesis
  • Receptors, IgG / immunology*

Substances

  • HLA-DR Antigens
  • Immunosuppressive Agents
  • Lipopolysaccharide Receptors
  • Macrophage-1 Antigen
  • Receptors, Complement 3b
  • Receptors, IgG
  • Etoposide
  • Dexamethasone
  • Cyclosporine